A Revolutionary Organ Preservation Discovery biotechnology company looking to raise funds USD 10 million

Posted On: 03 / Sep / 2022
0 636

Deal Details

Annual

Deal Type

Equity (Fundraise)
Maximum Loan

Industry

Medical Equipment
Charge

Deal Status

Active

Deal Description

How does ElaPharma prevent cell death? Small molecules the enzyme CELA3A- which is invlved in celluar death via necrosis have been identified, developed , and patented.

ElaPharma is the first to target the final effector mechanism common to all diseases at the their endpoint effectively stopping necrosis.

Attached Files

icon Ela Pharma Organ Preservation solution (1) pptx

Deal Value
79.9 Crore
Targeted Region
Americas

Revenue

2019-20
Undisclosed
2020-21
Undisclosed
2021-22
Undisclosed